Blockade of the CD47-SIRPA signaling pathway initiates an adaptive immune response to kill tumor cells
Blockade of the CD47-SIRPα signaling pathway initiates an adaptive immune response to kill tumor cells. Blockade of the CD47-SIRPα signaling axis inhibits the degradation of tumor-derived mtDNA through the activation of NOX2, which, once in the cytoplasm of the DC, is recognized by cGAS, further activating the cGAS-cGAMP-STING signaling pathway to release INF-γ, thus promoting T cells to initiate adaptive immune response and kill tumor cells (schematic generated with figdraw). mtDNA, mitochondrial DNA; DC, dendritic cell; NOX, NADPH oxidase; cGAMP, cyclic GMP-AMP; cGAS, cGAMP synthase; INF, interferon; STING, INF gene stimulating factor
Progress in cancer research on the regulator of phagocytosis CD47, which determines the fate of tumor cells (Review) (2024)
Fan Wu, et al. Oncol Lett. 2024 Jun;27(6). Figure: F3.